Tasly Pharmaceutical Group Co., Ltd

Shanghai Stock Exchange 600535.SS

Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2023: USD 362.78 M

Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow is USD 362.78 M for the year ending December 31, 2023, a 9.55% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 331.14 M, a -24.89% change year over year.
Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 440.85 M, a 60.65% change year over year.
Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 274.41 M, a 13.73% change year over year.
Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2019 was USD 241.27 M, a 11.08% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 600535.SS

Tasly Pharmaceutical Group Co., Ltd

CEO	Mr. Jing Su
IPO Date	Aug. 23, 2002
Location	China
Headquarters	Tasly TCM Garden
Employees	9,223
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Tasly Pharmaceutical Group Co., Ltd. engages in biological medicine, health, and medical service businesses in China. It offers herbal and chemical medicines, health products, pharmaceutical substances and APIs, herbal extracts, concentrated herbal granules, and tea series products. The company also provides cosmetic series products, including moisture lotions, moisture creams, eye creams, and face washing foams; daily hygiene products, such as sanitary and carefree pads, honey-propolis soaps, and pollen soaps; and medical equipment, which include massage tappers, massage cushions, and circulation machines. It also exports its products to the United States, Russia, and countries in Europe, Africa, and rest of Asia. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, China.

Key trends

Past 5 years